Found: 16
Select item for more details and to access through your institution.
Cellular Mechanisms Underlying Eosinophilic and Neutrophilic Airway Inflammation in Asthma.
- Published in:
- Mediators of Inflammation, 2015, v. 2015, p. 1, doi. 10.1155/2015/879783
- By:
- Publication type:
- Article
Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis.
- Published in:
- Journal of Asthma & Allergy, 2021, v. 14, p. 1165, doi. 10.2147/JAA.S328988
- By:
- Publication type:
- Article
Update on optimal use of omalizumab in management of asthma.
- Published in:
- Journal of Asthma & Allergy, 2011, v. 4, p. 49, doi. 10.2147/JAA.S14520
- By:
- Publication type:
- Article
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma.
- Published in:
- BioMed Research International, 2018, v. 2018, p. 1, doi. 10.1155/2018/4839230
- By:
- Publication type:
- Article
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1121237
- By:
- Publication type:
- Article
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, p. 1, doi. 10.1177/1753466620963016
- By:
- Publication type:
- Article
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, p. 1, doi. 10.1177/1753466620963016
- By:
- Publication type:
- Article
Review: Omalizumab in the treatment of severe asthma: efficacy and current problems.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2008, v. 2, n. 6, p. 409, doi. 10.1177/1753465808100431
- By:
- Publication type:
- Article
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-77641-7
- By:
- Publication type:
- Article
Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.
- Published in:
- Drug Design, Development & Therapy, 2017, v. 11, p. 3137, doi. 10.2147/DDDT.S150656
- By:
- Publication type:
- Article
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma.
- Published in:
- SAGE Open Medical Case Reports, 2020, v. 8, p. 1, doi. 10.1177/2050313X20906963
- By:
- Publication type:
- Article
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report.
- Published in:
- Journal of Medical Case Reports, 2020, v. 14, n. 1, p. 1, doi. 10.1186/s13256-020-02595-3
- By:
- Publication type:
- Article
Application of proteomics and peptidomics to COPD.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Update on Anticytokine Treatment for Asthma.
- Published in:
- BioMed Research International, 2013, v. 2013, p. 1, doi. 10.1155/2013/104315
- By:
- Publication type:
- Article
Role of biologics in severe eosinophilic asthma - focus on reslizumab.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD.
- Published in:
- 2015
- By:
- Publication type:
- journal article